IP3R-I Polyclonal Antibody

ITPR1 (inositol 1,4,5-trisphosphate receptor type 1) encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in ITPR1 cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for ITPR1.

The IP3R-I Polyclonal Antibody is a highly specific and sensitive antibody that has been designed to detect and quantify the expression of IP3R-I protein in various biological samples. This antibody has been extensively validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The IP3R-I Polyclonal Antibody is produced using high-quality materials and state-of-the-art techniques to ensure maximum specificity and sensitivity. It has been rigorously tested to ensure that it does not cross-react with other proteins or interfere with other cellular processes.

This antibody is ideal for researchers who are interested in studying the role of IP3R-I in various biological processes, including calcium signaling, apoptosis, and cell proliferation. It is also useful for those who are interested in developing new therapies for diseases that are associated with IP3R-I dysfunction.

Overall, the IP3R-I Polyclonal Antibody is a reliable and effective tool for researchers who are interested in studying the function and regulation of IP3R-I protein in various biological systems. Its high specificity and sensitivity make it an ideal choice for a wide range of applications, and its rigorous validation ensures that it will provide accurate and reproducible results.